Annual Non Current Assets
$83.97 M
-$1.86 M-2.17%
December 31, 2023
Summary
- As of February 7, 2025, AXSM annual long term assets is $83.97 million, with the most recent change of -$1.86 million (-2.17%) on December 31, 2023.
- During the last 3 years, AXSM annual non current assets has risen by +$81.86 million (+3880.71%).
- AXSM annual non current assets is now -2.17% below its all-time high of $85.83 million, reached on December 31, 2022.
Performance
AXSM Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$82.34 M
-$2.85 M-3.35%
September 30, 2024
Summary
- As of February 7, 2025, AXSM quarterly long term assets is $82.34 million, with the most recent change of -$2.85 million (-3.35%) on September 30, 2024.
- Over the past year, AXSM quarterly non current assets has dropped by -$1.63 million (-1.94%).
- AXSM quarterly non current assets is now -10.45% below its all-time high of $91.95 million, reached on June 30, 2023.
Performance
AXSM Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
AXSM Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.2% | -1.9% |
| 3 y3 years | +3880.7% | +5130.6% |
| 5 y5 years | +10000.0% | +10000.0% |
AXSM Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.2% | +6528.2% | -10.4% | +6399.7% |
| 5 y | 5-year | -2.2% | >+9999.0% | -10.4% | >+9999.0% |
| alltime | all time | -2.2% | -100.0% | -10.4% | >+9999.0% |
Axsome Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $82.34 M(-3.3%) |
| Jun 2024 | - | $85.20 M(-0.0%) |
| Mar 2024 | - | $85.24 M(+1.5%) |
| Dec 2023 | $504.26 M(+105.3%) | $83.97 M(-5.7%) |
| Sep 2023 | - | $89.09 M(-3.1%) |
| Jun 2023 | - | $91.95 M(+8.5%) |
| Mar 2023 | - | $84.73 M(-1.3%) |
| Dec 2022 | $245.64 M(+183.9%) | $85.83 M(-0.9%) |
| Sep 2022 | - | $86.57 M(+13.0%) |
| Jun 2022 | - | $76.58 M(+4325.9%) |
| Mar 2022 | - | $1.73 M(+36.6%) |
| Dec 2021 | $86.52 M(-53.0%) | $1.27 M(-19.5%) |
| Sep 2021 | - | $1.57 M(-2.2%) |
| Jun 2021 | - | $1.61 M(-13.8%) |
| Mar 2021 | - | $1.87 M(-11.4%) |
| Dec 2020 | $184.02 M(-16.5%) | $2.11 M(+490.7%) |
| Sep 2020 | - | $357.10 K(+109.7%) |
| Jun 2020 | - | $170.30 K(-4.4%) |
| Mar 2020 | - | $178.10 K(+4.5%) |
| Dec 2019 | $220.38 M | $170.50 K(-16.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $203.50 K(-3.0%) |
| Jun 2019 | - | $209.70 K(+47.8%) |
| Mar 2019 | - | $141.90 K(-13.6%) |
| Dec 2018 | $15.22 M(-56.9%) | $164.20 K(-9.5%) |
| Sep 2018 | - | $181.40 K(-2.5%) |
| Jun 2018 | - | $186.00 K(+0.2%) |
| Mar 2018 | - | $185.60 K(-27.5%) |
| Dec 2017 | $35.30 M(-7.1%) | $256.00 K(+28.9%) |
| Sep 2017 | - | $198.60 K(-3.5%) |
| Jun 2017 | - | $205.80 K(-3.3%) |
| Mar 2017 | - | $212.80 K(-0.4%) |
| Dec 2016 | $38.00 M(-22.5%) | $213.60 K(+30.6%) |
| Sep 2016 | - | $163.60 K(+79.2%) |
| Jun 2016 | - | $91.30 K(+10.4%) |
| Mar 2016 | - | $82.70 K(+91.0%) |
| Dec 2015 | $49.03 M(+1687.0%) | $43.30 K(-96.3%) |
| Sep 2015 | - | $1.17 M(+464.1%) |
| Jun 2015 | - | $207.80 K(+387.8%) |
| Dec 2014 | $2.74 M(+30.8%) | $42.60 K |
| Dec 2013 | $2.10 M | - |
FAQ
- What is Axsome Therapeutics annual long term assets?
- What is the all time high annual non current assets for Axsome Therapeutics?
- What is Axsome Therapeutics annual non current assets year-on-year change?
- What is Axsome Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly non current assets year-on-year change?
What is Axsome Therapeutics annual long term assets?
The current annual non current assets of AXSM is $83.97 M
What is the all time high annual non current assets for Axsome Therapeutics?
Axsome Therapeutics all-time high annual long term assets is $85.83 M
What is Axsome Therapeutics annual non current assets year-on-year change?
Over the past year, AXSM annual long term assets has changed by -$1.86 M (-2.17%)
What is Axsome Therapeutics quarterly long term assets?
The current quarterly non current assets of AXSM is $82.34 M
What is the all time high quarterly non current assets for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly long term assets is $91.95 M
What is Axsome Therapeutics quarterly non current assets year-on-year change?
Over the past year, AXSM quarterly long term assets has changed by -$1.63 M (-1.94%)